Trial Profile
A phase II study of TAK-442 in patients with arterial thrombosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 May 2016
Price :
$35
*
At a glance
- Drugs Letaxaban (Primary)
- Indications Arterial thrombosis
- Focus Adverse reactions
- Sponsors Takeda
- 26 May 2016 New trial record